Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02630225 · ClinicalTrials.gov registry record · NA

Helping Individuals With Firearm Injuries

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
232
Enrollment target

NCT02630225 is a NA study that has completed, run by University of Washington. The registered enrollment target is 232 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02630225, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
232 participants
Enrollment target

Study Summary

The investigators will conduct a cluster randomized trial of an intervention program that combines a hospital-based intervention, structured outreach program, and multi-agency attention. The goal of the study is to test the effect of this multi-component intervention on criminal activity, injury, substance abuse, mental health, quality of life, violent behavior, and death. Investigators aim to enroll a total of 300 patients admitted to the Harborview Medical Center (HMC) for firearm-related injuries. Patients will be randomized to receive a multi-component intervention or treatment as usual. All participants will complete surveys at the time of study consent (baseline) and then at designated time points for 12 months post-consent. Study staff will routinely collect participant records from Washington State Patrol records, HMC medical records, Washington State trauma registry, Washington State Emergency Department Information Exchange, Administrative Office of the Courts, and vital records. The investigators will test the impact of the intervention against standard care. The hypothesis is that participants in the intervention group will see greater improvements in aforementioned outcomes than those in the control group.

Interventions

  • BEHAVIORAL Motivational Interviewing
  • OTHER Treatment as Usual
  • BEHAVIORAL Critical Time Intervention
  • OTHER Multi-Agency Attention

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2016-03-23
Est. Completion 2019-12-31
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT02630225

The ClinicalTrials.gov registry entry for NCT02630225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Motivational Interviewing is the first listed.

NCT02630225 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02630225 about?

NCT02630225 is a clinical study titled "Helping Individuals With Firearm Injuries". The investigators will conduct a cluster randomized trial of an intervention program that combines a hospital-based intervention, structured outreach program, and multi-agency attention. The goal of the study is to test the effect of this multi-component intervention on criminal activity, injury, su...

What is the current status of trial NCT02630225?

This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2016-03-23. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT02630225?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Treatment as Usual (OTHER), Critical Time Intervention (BEHAVIORAL), Multi-Agency Attention (OTHER).

Who is sponsoring clinical trial NCT02630225?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.